Lukas P Frenzel
Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells.
Göckeritz E, Kerwien S, Baumann M, Wigger M, Vondey V, Neumann L, Landwehr T, Wendtner C, Klein C, Liu N, Hallek M, Frenzel L, Krause G. Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells. Int J Cancer 2015; 137:2234-42.
May 12, 2015Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells.
May 12, 2015Int J Cancer 2015; 137:2234-42
Göckeritz Elisa, Kerwien Susan, Baumann Michael, Wigger Marion, Vondey Verena, Neumann Lars, Landwehr Thomas, Wendtner Clemens M, Klein Christian, Liu Ningshu, Hallek Michael, Frenzel Lukas P, Krause Günter
B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides.
Schwamb J, Feldhaus V, Baumann M, Patz M, Brodesser S, Brinker R, Claasen J, Pallasch C, Hallek M, Wendtner C, Frenzel L. B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides. Blood 2012; 120:3978-85.
Aug 27, 2012B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides.
Aug 27, 2012Blood 2012; 120:3978-85
Schwamb Janine, Feldhaus Valeska, Baumann Michael, Patz Michaela, Brodesser Susanne, Brinker Reinhild, Claasen Julia, Pallasch Christian P, Hallek Michael, Wendtner Clemens-Martin, Frenzel Lukas P